Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis
Open Access
- 1 May 2022
- journal article
- research article
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 37 (1) , 1-9
Abstract
Objectives. People living with HIV (PLHIV) are susceptible to develop dyslipidemia and hyperglycemia. This study aims to determine the prevalence of these metabolic derangements among Filipino PLHIV. Methodology. We reviewed 635 medical records in a treatment hub in Manila, Philippines from January 2004 to July 2016. Logistic regression analysis was done to determine factors associated with dyslipidemia and hyperglycemia pre and post-ART. Results. Among 635 PLHIV, 97.3% were males with mean age of 30 years and median CD4 count of 207 cells/mm(3). Pre-ART, prevalence of dyslipidemia was 65.4% and hyperglycemia was 10.4%. Risk factors for dyslipidemia include hyperglycemia (AOR 3.8, p 0.001) and >320 days delay in ART initiation from HIV confirmation (AOR 1.5, p 0.032), while dyslipidemia was associated with hyperglycemia (AOR 3.1, p 0.001). Post-ART, prevalence of dyslipidemia was 48.6% and hyperglycemia was 15.6%. Risk factors for post-ART dyslipidemia include being WHO stage 4 (AOR 2.1, p 0.021), hyperglycemia (AOR 16.1, p36 months ART duration (AOR 8.7, p<0.001) and efavirenz-based ART (AOR 2.8, p30 years (AOR 2.1, p 0.004), being overweight (AOR 1.8, p 0.023), dyslipidemia (AOR 17.8, p<0.001) and zidovudine-based ART (AOR 1.4, p 0.051). Conclusion. Dyslipidemia and hyperglycemia prevalence was high in Filipino PLHIV. Traditional, HIV and treatment related factors contributed to its development. Intensive monitoring and initiation of appropriate treatment is recommended.Keywords
This publication has 41 references indexed in Scilit:
- Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspectsAIDS Research and Therapy, 2013
- Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional surveyBMC Public Health, 2013
- Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART)BMC Endocrine Disorders, 2013
- Lipid Profile of Anti-Retroviral Treatment-Naοve HIV-Infected Patients in Jos, NigeriaAnnals of Medical and Health Sciences Research, 2013
- Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in JapanJournal of Infection and Chemotherapy, 2012
- Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and managementEndocrine, 2011
- Dyslipidemia in an HIV-Positive Antiretroviral Treatment-Naive Population in Dar es Salaam, TanzaniaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- HIV protease inhibitors and obesityCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient PopulationClinical Infectious Diseases, 2007
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004